WO2015170286A3 - Modulation of blood glucose levels - Google Patents
Modulation of blood glucose levels Download PDFInfo
- Publication number
- WO2015170286A3 WO2015170286A3 PCT/IB2015/053360 IB2015053360W WO2015170286A3 WO 2015170286 A3 WO2015170286 A3 WO 2015170286A3 IB 2015053360 W IB2015053360 W IB 2015053360W WO 2015170286 A3 WO2015170286 A3 WO 2015170286A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- blood glucose
- glucose levels
- modulation
- diabetes
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention provides methods and compositions for modulating blood glucose levels, and methods and compositions for use in the treatment of diabetes, in particular type 2 diabetes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2014901695 | 2014-05-08 | ||
AU2014901695A AU2014901695A0 (en) | 2014-05-08 | Modulation of blood glucose levels |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2015170286A2 WO2015170286A2 (en) | 2015-11-12 |
WO2015170286A3 true WO2015170286A3 (en) | 2016-01-28 |
Family
ID=54251539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2015/053360 WO2015170286A2 (en) | 2014-05-08 | 2015-05-08 | Modulation of blood glucose levels |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2015170286A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016168388A2 (en) | 2015-04-14 | 2016-10-20 | Palatin Technologies, Inc. | Therapies for obesity, diabetes and related indications |
JP2020508978A (en) * | 2017-02-28 | 2020-03-26 | バイオリンガス アイピー エルエルシー | Oil-based formulation for sublingual and buccal delivery |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009080032A1 (en) * | 2007-12-20 | 2009-07-02 | Fertin Pharma A/S | Compressed chewing gum comprising a systemically active small peptide |
EP2389945A1 (en) * | 2010-05-28 | 2011-11-30 | Sanofi-Aventis Deutschland GmbH | Pharmaceutical composition comprising AVE0010 and insulin glargine |
WO2012109694A1 (en) * | 2011-02-18 | 2012-08-23 | Sai Ying Ko | Process for preparing products comprising stabilised actives and compositions comprising same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6974590B2 (en) | 1998-03-27 | 2005-12-13 | Cima Labs Inc. | Sublingual buccal effervescent |
AUPR272901A0 (en) | 2001-01-25 | 2001-02-22 | Gainful Plan Limited | Method of preparing biological materials and preparations produced using same |
-
2015
- 2015-05-08 WO PCT/IB2015/053360 patent/WO2015170286A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009080032A1 (en) * | 2007-12-20 | 2009-07-02 | Fertin Pharma A/S | Compressed chewing gum comprising a systemically active small peptide |
EP2389945A1 (en) * | 2010-05-28 | 2011-11-30 | Sanofi-Aventis Deutschland GmbH | Pharmaceutical composition comprising AVE0010 and insulin glargine |
WO2012109694A1 (en) * | 2011-02-18 | 2012-08-23 | Sai Ying Ko | Process for preparing products comprising stabilised actives and compositions comprising same |
Also Published As
Publication number | Publication date |
---|---|
WO2015170286A2 (en) | 2015-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3449956A4 (en) | Medical hydrogel composition, and medical hydrogel, preparation method therefor and application thereof | |
EP3675714A4 (en) | Devices and methods for vascular navigation, assessment and/or diagnosis | |
WO2016172658A3 (en) | Microbiome regulators and related uses thereof | |
WO2016100985A3 (en) | Chimeric antigen receptors and methods of use thereof | |
EA201270803A1 (en) | TIOACATETIC COMPOUNDS, COMPOSITIONS ON THEIR BASIS AND METHODS OF THEIR APPLICATION | |
EP3095855A4 (en) | Efficient bottom treatment bacillus, composite bottom treatment inoculant prepared using same and applications thereof | |
EA201790434A1 (en) | CHANNEL MODULATORS | |
EP3411504A4 (en) | Anti-tnf antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes | |
WO2015179559A3 (en) | Pyrazole compounds and methods of making and using same | |
WO2013158844A3 (en) | Color correcting compositions and methods of use thereof | |
WO2017023933A3 (en) | Peptidomimetic macrocycles | |
EP3117802A4 (en) | Stent with mechanical or biological heart valve for minimally invasive valve replacement procedure, and applicator | |
EP3451908A4 (en) | Devices and methods for vascular navigation, assessment and/or diagnosis | |
EP3297641A4 (en) | Methods for the storage of whole blood, and compositions thereof | |
WO2015191951A3 (en) | Modulation of complement activity | |
MX2018000352A (en) | Substituted 4-azaindoles and their use as glun2b receptor modulators. | |
PH12018500887A1 (en) | Anti-htra1 antibodies and methods of use thereof | |
WO2017087916A3 (en) | Thermostable glucose biosensors and uses thereof | |
MX2018002543A (en) | Compositions comprising urolithin compounds. | |
WO2017087912A3 (en) | Ratiometric biosensors and non-geometrically modulated fret | |
MX2018002546A (en) | Compositions comprising an urolithin compound. | |
WO2013120022A3 (en) | Treatment of hypoglycemia | |
WO2016014342A3 (en) | Ang-(1-7) derviative oligopeptides and methods for using and producing the same | |
WO2016007540A3 (en) | Compositions and methods for treating dengue virus infection | |
MX2018005987A (en) | Heterocyclic compounds for the treatment of disease. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15774966 Country of ref document: EP Kind code of ref document: A2 |